Hilel Lewis. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Fibrinolytic Agents/administration & dosageFibrinolytic Agents/therapeutic useHumansInjectionsMacular Degeneration/complicationsPrognosisRetinal Hemorrhage/drug therapyRetinal Hemorrhage/etiologySulfur Hexafluoride/administration & dosageSulfur Hexafluoride/therapeutic useTissue Plasminogen Activator/administration & dosageTissue Plasminogen Activator/therapeutic useVisual Acuity
Substances: See more » Fibrinolytic AgentsTissue Plasminogen ActivatorSulfur Hexafluoride
Year: 2002 PMID: 11986071 DOI: 10.1016/s0161-6420(02)01005-9
Source DB: PubMed Journal: Ophthalmology ISSN: 0161-6420 Impact factor: 12.079